Rosen, trusted investor counsel, encourages sarepta therapeutics, inc. investors to inquire about securities class action investigation - srpt

New york , nov. 4, 2023 /prnewswire/ -- why:  rosen law firm, a global investor rights law firm, continues investigating potential securities claims on behalf of shareholders of sarepta therapeutics, inc. (nasdaq: srpt) resulting from allegations that sarepta may have issued materially misleading business information to the investing public. so what: if you purchased sarepta securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
SRPT Ratings Summary
SRPT Quant Ranking